(Reuters) – Macau’s government said on Wednesday it has suspended the use of the COVID-19 vaccine developed by BioNTech SE due to defects found in the caps of some vials.
BioNTech and Fosun Pharma, which is the distributor of the vaccines for the Greater China region, have no reason to believe there is a product-safety risk, the Macau government said in a statement.
(Reporting by Beijing newsroom; Writing by Se Young Lee; Editing by Christopher Cushing)
